CA1339066C - Disinfecting compositions and methods therefor - Google Patents
Disinfecting compositions and methods thereforInfo
- Publication number
- CA1339066C CA1339066C CA000617009A CA617009A CA1339066C CA 1339066 C CA1339066 C CA 1339066C CA 000617009 A CA000617009 A CA 000617009A CA 617009 A CA617009 A CA 617009A CA 1339066 C CA1339066 C CA 1339066C
- Authority
- CA
- Canada
- Prior art keywords
- composition
- acid
- chlorite
- weight
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 207
- 230000000249 desinfective effect Effects 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title claims description 18
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 claims abstract description 82
- 239000002253 acid Substances 0.000 claims abstract description 43
- 229910001919 chlorite Inorganic materials 0.000 claims abstract description 43
- 229910052619 chlorite group Inorganic materials 0.000 claims abstract description 43
- 150000001875 compounds Chemical class 0.000 claims abstract description 39
- 229940077239 chlorous acid Drugs 0.000 claims abstract description 33
- 229910052751 metal Inorganic materials 0.000 claims abstract description 27
- 239000002184 metal Substances 0.000 claims abstract description 27
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 24
- QBWCMBCROVPCKQ-UHFFFAOYSA-M chlorite Chemical compound [O-]Cl=O QBWCMBCROVPCKQ-UHFFFAOYSA-M 0.000 claims abstract description 23
- 229940005993 chlorite ion Drugs 0.000 claims abstract description 23
- 239000000796 flavoring agent Substances 0.000 claims abstract description 21
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 20
- 239000007864 aqueous solution Substances 0.000 claims abstract description 15
- 239000004310 lactic acid Substances 0.000 claims abstract description 12
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 12
- 150000007524 organic acids Chemical class 0.000 claims description 19
- UKLNMMHNWFDKNT-UHFFFAOYSA-M sodium chlorite Chemical group [Na+].[O-]Cl=O UKLNMMHNWFDKNT-UHFFFAOYSA-M 0.000 claims description 16
- 229960002218 sodium chlorite Drugs 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 6
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 5
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 claims description 4
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 claims description 4
- 108010011485 Aspartame Proteins 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 3
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 claims description 3
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 2
- 239000005844 Thymol Substances 0.000 claims description 2
- 239000010630 cinnamon oil Substances 0.000 claims description 2
- 239000010634 clove oil Substances 0.000 claims description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 2
- 229940041616 menthol Drugs 0.000 claims description 2
- 235000019477 peppermint oil Nutrition 0.000 claims description 2
- 235000019204 saccharin Nutrition 0.000 claims description 2
- 229940081974 saccharin Drugs 0.000 claims description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 claims description 2
- 229960000790 thymol Drugs 0.000 claims description 2
- 239000009637 wintergreen oil Substances 0.000 claims description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 claims 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 claims 1
- 229960005233 cineole Drugs 0.000 claims 1
- 150000003870 salicylic acids Chemical class 0.000 claims 1
- 239000002324 mouth wash Substances 0.000 abstract description 17
- 238000009472 formulation Methods 0.000 abstract description 16
- 239000000645 desinfectant Substances 0.000 abstract description 15
- 239000000606 toothpaste Substances 0.000 abstract description 14
- 208000002064 Dental Plaque Diseases 0.000 abstract description 12
- 239000000460 chlorine Substances 0.000 abstract description 4
- 229910052801 chlorine Inorganic materials 0.000 abstract description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract description 3
- OSVXSBDYLRYLIG-UHFFFAOYSA-N dioxidochlorine(.) Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 65
- 239000000499 gel Substances 0.000 description 38
- 239000004155 Chlorine dioxide Substances 0.000 description 31
- 235000019398 chlorine dioxide Nutrition 0.000 description 31
- 239000000243 solution Substances 0.000 description 23
- 229920000642 polymer Polymers 0.000 description 20
- -1 sodium chlorite Chemical class 0.000 description 14
- 229940051866 mouthwash Drugs 0.000 description 13
- 150000003839 salts Chemical class 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 208000004396 mastitis Diseases 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 229940034610 toothpaste Drugs 0.000 description 9
- ULDHMXUKGWMISQ-SECBINFHSA-N (-)-carvone Chemical compound CC(=C)[C@@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-SECBINFHSA-N 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 210000002445 nipple Anatomy 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 201000001245 periodontitis Diseases 0.000 description 7
- 239000002562 thickening agent Substances 0.000 description 7
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 6
- 208000007565 gingivitis Diseases 0.000 description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 6
- 238000006116 polymerization reaction Methods 0.000 description 6
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 6
- 235000010234 sodium benzoate Nutrition 0.000 description 6
- 239000004299 sodium benzoate Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 150000001298 alcohols Chemical class 0.000 description 5
- 210000000481 breast Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 5
- 239000003349 gelling agent Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 229940042129 topical gel Drugs 0.000 description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 4
- 241000283690 Bos taurus Species 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 4
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 239000002585 base Substances 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- RARSHUDCJQSEFJ-UHFFFAOYSA-N p-Hydroxypropiophenone Chemical compound CCC(=O)C1=CC=C(O)C=C1 RARSHUDCJQSEFJ-UHFFFAOYSA-N 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 239000012190 activator Substances 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 150000001735 carboxylic acids Chemical class 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 150000001805 chlorine compounds Chemical class 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 239000008121 dextrose Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 3
- 239000007937 lozenge Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003641 microbiacidal effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229940068196 placebo Drugs 0.000 description 3
- 239000000902 placebo Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- HORNXRXVQWOLPJ-UHFFFAOYSA-N 3-chlorophenol Chemical compound OC1=CC=CC(Cl)=C1 HORNXRXVQWOLPJ-UHFFFAOYSA-N 0.000 description 2
- 241000606750 Actinobacillus Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 230000002070 germicidal effect Effects 0.000 description 2
- 244000144980 herd Species 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 230000005923 long-lasting effect Effects 0.000 description 2
- 239000008368 mint flavor Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- UEUXEKPTXMALOB-UHFFFAOYSA-J tetrasodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O UEUXEKPTXMALOB-UHFFFAOYSA-J 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- AOSFMYBATFLTAQ-UHFFFAOYSA-N 1-amino-3-(benzimidazol-1-yl)propan-2-ol Chemical compound C1=CC=C2N(CC(O)CN)C=NC2=C1 AOSFMYBATFLTAQ-UHFFFAOYSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000606749 Aggregatibacter actinomycetemcomitans Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 229910014033 C-OH Inorganic materials 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 229910014570 C—OH Inorganic materials 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 101100114828 Drosophila melanogaster Orai gene Proteins 0.000 description 1
- RZSYLLSAWYUBPE-UHFFFAOYSA-L Fast green FCF Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC(O)=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 RZSYLLSAWYUBPE-UHFFFAOYSA-L 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000286904 Leptothecata Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 244000227633 Ocotea pretiosa Species 0.000 description 1
- 235000004263 Ocotea pretiosa Nutrition 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241001149563 Streptococcus mutans ATCC 25175 Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 235000019445 benzyl alcohol Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000012986 chain transfer agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- BIWJNBZANLAXMG-UHFFFAOYSA-N chlordane Chemical compound ClC1=C(Cl)C2(Cl)C3CC(Cl)C(Cl)C3C1(Cl)C2(Cl)Cl BIWJNBZANLAXMG-UHFFFAOYSA-N 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229940097572 chloromycetin Drugs 0.000 description 1
- LFHISGNCFUNFFM-UHFFFAOYSA-N chloropicrin Chemical compound [O-][N+](=O)C(Cl)(Cl)Cl LFHISGNCFUNFFM-UHFFFAOYSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000002316 fumigant Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 150000004001 inositols Chemical class 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000002267 larvicidal agent Substances 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AJDUTMFFZHIJEM-UHFFFAOYSA-N n-(9,10-dioxoanthracen-1-yl)-4-[4-[[4-[4-[(9,10-dioxoanthracen-1-yl)carbamoyl]phenyl]phenyl]diazenyl]phenyl]benzamide Chemical compound O=C1C2=CC=CC=C2C(=O)C2=C1C=CC=C2NC(=O)C(C=C1)=CC=C1C(C=C1)=CC=C1N=NC(C=C1)=CC=C1C(C=C1)=CC=C1C(=O)NC1=CC=CC2=C1C(=O)C1=CC=CC=C1C2=O AJDUTMFFZHIJEM-UHFFFAOYSA-N 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000001967 plate count agar Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- FQLQNUZHYYPPBT-UHFFFAOYSA-N potassium;azane Chemical compound N.[K+] FQLQNUZHYYPPBT-UHFFFAOYSA-N 0.000 description 1
- VISKNDGJUCDNMS-UHFFFAOYSA-M potassium;chlorite Chemical compound [K+].[O-]Cl=O VISKNDGJUCDNMS-UHFFFAOYSA-M 0.000 description 1
- 238000010944 pre-mature reactiony Methods 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000007143 thioglycolate medium Substances 0.000 description 1
- NJRXVEJTAYWCQJ-UHFFFAOYSA-N thiomalic acid Chemical compound OC(=O)CC(S)C(O)=O NJRXVEJTAYWCQJ-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 229940100611 topical cream Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000003253 viricidal effect Effects 0.000 description 1
- 239000001043 yellow dye Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
There is disclosed, in one aspect, a disinfectant oral hygiene composition for reducing dental plaque which comprises a flavouring agent acceptable for oral hygiene compositions, an aqueous solution containing a suitable amount of an acid, and an amount of a metal chlorite such that the chlorite ion concentration in the form of chlorous acid is no more than about 15 percent by weight of the total amount of chlorite ion concentration. The composition contains substantially no lactic acid. The oral hygiene formulations of this invention contain low concentrations of chlorous acid generating compounds which are extremely effective as oral disinfectants. These compositions provide effective mouthwashes, toothpastes and other oral disinfecting compositions without the strong characteristic unpleasant taste of chlorine.
Description
Description DISINFECTING COMPOSITIONS AND METHODS THEREFOR
This is a divisional application of Application Serial No. 563,942.
Technical Field This invention relates generally to compositions for disinfecting substrates as well as to processes for preparing and using such compositions. Further, this invention relates to disinfecting compositions useful as oral hygiene compositions such as a mouthwash, toothpaste, lozenge, chewing gum, or the like.
Background of the Invention The term "disinfectant" is used in this specification to broadly include any substance or composition that disinfects, sanitizes, deodorizes, sterilizes, or kills germs.
The use of chlorine compounds in various types of disinfectant compositions is well known. Chlorine compounds suggested for use in this regard include, for example, sodium hypochlorite, used in World War I was a wound irrigant, and chlorinated phenols, such as m-chlorophenol. These compounds have increased bactericidal activity and reduced toxicity, in some instances, when compared to non-chlorinated phenols. Thus, m-chlorophenol has a phenol coefficient of 5.8 (S. aureus) to 7.4 (B. typhosus). Other chlorine compounds having some form of disinfectant utility include, for example, chlorine gas itself, chlorine dioxide, chloramine T, calcium hypochlorite (a standard swimming pool disinfectant), chloropicrin (a larvicide), chloroform (a fumigant), chlorodane (an insecticide), and chloromycetin (an antibiotic).
Chlorine dioxide in particular has been found to be an especially effective disinfectant. This compound is quite versatile and has long been used as a bleaching agent, such as in the oxidizing of the natural colorant *
present in cotton, wood pulp and other cellulosic fibrous material. In such uses, chlorine dioxide, though perform- t ing an oxidizing function, is nevertheless noninjurious with respect to the fibrous material.
Particularly useful disinfecting compositions which employ chlorine-containing compounds are disclosed in U.S. Patent Nos. 4,330,531 and 4,585,482. These composi-tions comprise chlorite salts, such as sodium chlorite, in combination with weak organic acids, such as lactic acid, to provide particularly effective disinfectant compositions.
These compositions are useful in topically treating skin diseases such as acne and in toothpastes.
One particularly preva]ent disease is mastitis in dairy herds. Mastitis is a highly infectious disease which affects the bovine udder. l'he losses in dairy production resulting from this disease are staggering. For example, in the United States alone, these losses are estimated to be in the hundreds of millions of dollars. Mastitis not only reduces the production of higher yielding animals, but also shortens their productive life.
It is well known that mastitis is transmitted from animal to animal. It has also been established that the only route of transmission of the disease is through the teat orifice. Conditions which are help primarily responsible for the high incidence of mastitis include poor udder hygiene and physical damage to the teats. Dairymen and veterinarians have long sought a conditioning and protective composition which is economical and also provides facility of use. A composition which would improve the normal condition of the udder and teats and would also aid in preventing or effectively reducing the incidence of mastitis would serve to substantially increase both the production and productive life of a dairy herd.
Infectious mastitis is caused by microorganisms.
Prior art treatments, such as the use of sulfanilimide, have been only partially effective in controlling the disease because such treatments are useful against only one type of microorganism which causes mastitis but are not useful against other types. Since the infection is usually of a mixed character, it fol~ows that the ef~ectiveness of drugs such as sulfanilimide is limited for all practical purposes.
It has also been suggested to use penicillin for the treatment of mastitis. The use of this compound is not desirable, however, in view of the high cost and extraordi-nary conditions necessary for the preservation and use of penicillin It has been proposed in U.S. Patent No. 3,222,252 to treat mastitis with a preparation which comprises a - blend of edible, semidrying oils and drying oils together with a fatty acid ester, skin emollient, film-forming agent.
It is said that the presence of a drying oil in the prepara-tion is essential to provide the desired ~ilm-forming property. But for the most part, these film-forming-based treatments of mastitis have been unsuccessful. The use of iodine and peroxide in conjunction with latex emulsion films has led to other problems, including milk contamina-tion and skin irritation.
While chlorine-liberating compounds have germicidal and deodorant properties, their characteristic taste and odor make them unpleasant for use in oral hygiene compositions such as mouthwashes. Other oral hygiene compositions, some commercially avai]able, while pleasant tasting, are ineffective to reduce dental plaque as well as control gingivitis and periodontitis.
The search has continued for new and improved oral hygiene compositions which are both pleasant tasting and effective in reducing dental plaque as well as control gingivitis and periodontitis. This invention was made as a result of that search.
The use of compositions comprising metal chlorite and a weak organic acid, such as lactic acid, is disclosed in U.S. Patent No. 4,330,531. A chlorine dioxide releasing compound offers to substantially alleviate the problems associated with the prevention of mastitis. For this, application, the use of a gelling agent to generate a viscous topical gel is essential. The viscosity is needed for proper adhesion to the skin surface for an extended length of time.
Past attempts to create a useful viscous topical gel containing chlorine dioxide releasing compounds have been less than completely successful. Of the gelling agents tried, none combined the properties needed for substantial effectiveness.
Carbohydrate-based gels lose their viscosity at higher pH's as the alkaline chlorites break down the long polymer chains.
Inorganic thickeners, such as bentonite clays, participate in the reaction between the acid and chlorite, and tend to form stringy, unsuitable gels.
The search has continued for a viscous topical gel composition capable of embodying alkaline chlorites for the treatment and prevention of skin disease, infection and irritation on humans and other ~n;m~ls. This invention was made as a result of that search.
Obiects and Summary of the Invention Accordingly, it is a general object of the present invention to avoid or substantially alleviate the above-identified problems of the prior art.
Another object of the present invention is to provide improved oral hygiene compositions useful in reducing dental plaque.
A further object of the present invention is to provide oral hygiene compositions which are pleasant tasting yet effective to reduce dental plaque and control gingivitis and periodontitis.
An additional object of this invention is to provide, a method for producing these oral hygiene compositions.
Yet another object of this invention is to provide a method for disinfecting the mouth comprising treating the mouth with these oral hygiene compositions.
Other objects and advantages of the present invention will become apparent from the following summary of the invention and description of its preferred embodiments.
The present invention provides, in one aspect, a disinfectant oral hygiene composition for reducing dental plaque.
This composition comprises: (a) a flavouring agent acceptable for oral hygiene compositions, (b) an aqueous solution containing a suitable amount of an acid, and (c) an amount of a metal chlorite such that the chlorite ion concentration in the form of chlorous acid is no more than about 15 percent by weight of the total amount of chlorite ion concentration. The composition contains substantially no lactic acid.
In another aspect, the present invention provides a process for producing these disinfectant oral hygiene compositions. This process comprises admixing (a) a flavouring agent acceptable for oral hygiene compositions, (b) from about 0.03 to about 0.3 percent by weight of a chlorine dioxide liberating compound based upon the total weight of the composition, and (c) a suitable amount of an organic acid having a pK of from about 2.8 to about 4.2. The composition contains substantially no lactic acid.
In yet another aspect, the present invention provides a disinfectant oral hygiene composition for reducing dental plaque and controlling gingivitis and periodontitis, which composition comprises: (a) a flavouring agent acceptable for oral hygiene compositions, (b) from about 0.03 to about 0.3 percent by weight of a chlorine dioxide liberating compound based, upon the total weight of the composition, and (c) a suitable amount of an organic acid having a pK of from about 2.8 to about 4.2. The composition contains substantially no lactic acid.
In a further aspect, the present invention provides a composition comprising an aqueous solution or gel containing a suitable amount of a protic acid with an amount of a metal chlorite such that the chlorite metal ion concentration in the form of chlorous acid is no more than about 15 percent by weight of the total amount of chlorite ion concentration, the composition containing substantially no lactic acid.
There is also provided a disinfectant oral hygiene composition for reducing dental plaque which comprises a flavouring agent acceptable for oral hygiene compositions, an aqueous solution containing a compound which contains at least two vicinal hydroxy groups, a suitable amount of a protic acid, and an amount of metal chlorite such that the chlorite ion concentration in the form of a chlorous acid is no more than about 15 percent by weight of the total amount of chlorite ion concentration. The composition contains substantially no lactic acid.
1 339~66 The disinfecting compositions of this invention disinfect by means of a chlorous acid generating, composition. The composition comprises a flavoring agent, suitable amount of a carboxylic acid, and a suitable amount of a metal chlorite. The chlorite ion concentration in the form of chlorous acid is no more than about 15 5 percent by weight of the total amount of chlorite ion concentration.
The oral hygiene formulations of this invention contain low concentrations of chlorous acid generating compounds which are extremely effective as oral disinfectants. These compositions provide effective mouthwashes, toothpastes and other oral disinfecting compositions without the strong characteristic unpleasant taste 10 of chlorine.
DETAILED DESCRIPTION OF THE INVENTION
The composition of this invention is formed by combining one gel which comprises a dilute aqueous solution of metal chlorite with another gel which comprises a dilute aqueous solution containing a weak organic acid. The gel containing the metal 15 chlorite also contains the polysulfonic acid salt. The concentrations of chlorite and acid are relatively low.
This composition provides a metastable chlorous acid composition formed from small amounts of chlorite and acid. This composition is capable of generating chlorine dioxide over a long period of time at continuing levels of effectiveness.
'~, ~l,, As chlorine dioxide forms, more of the chlorite converts to chlorous acid by interacting with hydrogen ions further generated by ionization of the organic acid.
Weak organic acids which may be used in the present invention include 5 salicylic acid as well as citric, malic, tartaric, glycolic, mandelic and other structurally similar acids as described in Formula I hereinbelow:
FORMULA I
C-OH
R - C - OH
R' and R2 may be the same or different and may be selected from the 10 group consisting of hydrogen, methyl, -CH2COOH, -CH2OH, - CHOHCOOH, -C6H5 and -CH2C6H5. The pK of the organic acid is from about 2.8 to about 4.2, preferably from about 3.0 to about 4Ø
Compositions of a metal chlorite and the weak organic acids of Formula I are disclosed in United States Patent No. 4,986,990.
The gel containing the protic acid also contains a gelling agent or thickener which is well known to those skilled in this art. Any gelling agent or thickener which is nontoxic and nonreactive with the other ingredients of the composition may be used, such as cellulose gels, typically methyl cellulose, or preferably, hydroxy ethyl cellulose.
B
-8a-Furthermore, that gel may also contain a preservative, such as benzyl alcohol orsodium benzoate. Other additives, such as buffers to adjust the pH of the composition to become more compatible with the skin, may be used.
The amount of thickener in the protic acid-containing gel may be generally from about 0.5% to about 5%, typically from 0.8% to about 4%, and preferably from about 1% to about 3% of the gel, by weight, of the total composition. The amountof preservative in the gel may be generally from about 0.01% to about 0.05%, typically from about 0.01% to about 0.04%, and preferably from about 0.02% to about 3%, by weight, of the total composition.
The chlorine dioxide liberating compound or metal chlorite and the protic acid are present in separate gels, and the amount of the preservative is present in only that .~
1 33qo66 gel containing the protic acid. Approximately equal amounts of the separate gels should be used.
The gel containing metal chlorite is thickened with a -~lysulfonic acid salt. The amount of polysulfonic acid salt added will depend on the desired use of the resulting composition. For a topical cream, toothpaste, or topical gel for the treatment of facial acne, the amount of the thickener in the metal chlorite-containing gel may be generally from about 5% to about 15%, typically from about 5% to about 10%, and preferably from about 6% to about 8%, by weight, polysulfonic acid salt based upon the total composition. For a composition particularly suited to be used as a teat dip for treating cow udders, the amount of thickener in the metal chlorite-containing gel may be generally from about 0.5% to about 5%, typically from about 1% to about 4%, and preferably from about 2% to about 3%, by weight, solid polysulfonic acid salt based upon the total composition.
These polysulfonic acid salts are polymers of 2-acrylamido-2-methylpropane sulfonate. The preparation of such polymers is described in U.S. Patent No. 4,128,631, Canadian Patent No. 864,433, and German OLS No. 2,153,292, laid open May 4, 1972.
The pH of the gel containing the polysulfonic acid is generally greater than about 8, typically from about 9 to about 12, and preferably from about 10 to about 11.5.
The polymers useful in the present invention are prepared from:
O
CH2=CH-C-NH-C( CH2 ) -CH2S03H
or a salt thereof. The polymerization reaction may be accomplished by solution, emulsion, or suspension polymerization processes. The medium for the polymerization is conveniently water, an alcohol, or a mixture thereof. The choice of medium is best dictated by the requirements of the final composition to be formulated.
The polymerization reaction is temperature-, pll-and catalyst-sensitive. ln addition, it is desirable to exclude oxygen from the reaction vessel used to form the polymer, as that material inhibits the polymerization process. The catalysts which are included to enhance the rate of polymerization are materials such as ammonium bisulfite, ferrous sulfate, hydrogen peroxide, sodium metabisulfite, or other redox catalysts.
The polymer may be varied in molecular weight by controlling the amount of the cata]yst, the pll, or the rate of addition of the monomer to the reaction vessel. The polymerization may be faci]itated by converting the monomer from its acid form to a salt which is water-soluble.
The salts o~ the polymer preferably contain as cations, sodium, potassium ammonium, monethanolamine, diethanolamine, triethanolamine, and 2-amino-2-methyl-1-propanol as we]l as mixtures thereof. The foregoing list is merely exemplary of water-soluble salts which may be used. Also within the scope of the present invention are water-insoluble salts wherein the final composition is not adversely affected by precipitation of the polymer. Such products in which water-insoluble salts of the polymer may be utilized are toothpastes, or substan~ially nonaqueous products such as topical creams.
As was previously mentioncd, the molecular weight of the polymer may be controlled by the pll, the rate of addition of the monomer, or the judicious use of the cata-lyst. It has been found desirable to utilize the afore-described polymers having a molecular weight of from about 1,000,000 to about 5,000,000, more preferably from about 2,500,000 to about 4,500,000, to improve the viscosity and film-forming characteristics of the composition. That is, extremely high molecular weight polymers of the type described may result in a pituitive or stringy consistency of the end product. It has therefore been found desirable to limit the pituitiveness by selecting the preferred mole-cular weight range. To this end, any common chain transfer agent, such as mercaptosuccinic acid, may be used to limit the molecular weight of the polymer.
It is noted that the terminal groups on the polymer have little bearing on the desired properties of the final composition and are thus not specified. The terminal groups are most often hydrogens, but may also be hydroxyl, sulfate, sulfonate, or:
o ~t -CH2=CI~-C-NE~2 All alcohols, particularly the monhydric alcohols, may be used as ingredients with the polymer.
Alcohols (Cl-C2~) which are nonirritating to the skin, such as methanol, ethanol, isopropanol, propyl, lauryl, myristyl, cetyl, and stearyl, as well as mixtures thereof, are preferred. Polyols such as glycerine, or ethylene glycol or propylene glycol may be utilized advantageously with the polymer. The choice of the alcohol to be utilized with the particular polymer of the composition o~ the present invention will ordinarily be dictated by product aesthetics and the physical form of the composition. For instance, when liquid compositions are desired, the lower alcohols are preferably utilized, while cream compositions within the scope o~ the present invention will normally require the higher alcohols. Where the compositions of the present invention contain ingredients other than the polymer or the alcohol in substantial amounts, the choice of the particular alcohol becomes less important.
A desirable variable of the present invention is the incorporation of water with the polymer. A resuLtant increase in viscosity of the water is noted with no adverse effects on the stability of the product; that is, water is a highly suitable carrier which may be used as a vehicle for contacting the polymer and the substrate. The parti-cular weight ratios at which the desirable increase in - viscosity occurs for mixtures of the polymer and water are respective~y from about 1:10,000 to about 1:100. ~refer-ably this ratio is in the range of from about 1:1000 to about 1:500. Within the aforementioned range, highly - 5 viscous compositions are obtained with low solids content.
Such compositions are desirable in that they allow eomposi-tions such as topical creams or gels, acne gels, or teat dips to be formulated in a thickened state, providing greater ease of application.
~'he gel containing the protic acid and the gel containing the metal chlorite are mixed either before appli-cation to the affected substrate or preferably in situ.
After the gels are mixed, the pl~ of the final composition is generally less than about 7, typically from about 2 to about 5, and preferably from about 2.5 to about 4.
In the present invention, the composition is ordinarily used at a level of about 0.001 gram per square centimeter to about 0.1 gram per square centimeter of the affected substrate.
The oral hygiene compositions of this invention comprise a flavoring agent suitable for use in an oral hygiene composition, a suitable amount of a carboxylic - acid, and a suitable amount of a metal chlorite. The concentrations of chlorite and acid are relatively low and are such that the amount of chlorite in the form of chlorous acid is no more than about 15 percent by weight of the total chlorite ion concentration in solution.
Typically the amount of the chlorite in the form of chlorous acid is nor more than about 10 percent by weight of the total chlorite ion concentration in solution.
The percent by weight of chlorite and chlorous acid may be calculated from the ionization constant of chlorous acid and the amount of hydrogen ion in solution produced by the partial ionization of the carboxylic acid.
Thus the hydrogen ion concentration, IH+I, in a solution of the carboxylic acid, HA, of known molar concentration and whose ionization constant is KA~ may be calculated from the following relationship:
KA = [H+1 [A~]
[HA]
This same relationship may be applied to calculate the relative chlorite and chlorous acid concentrations where the ionization constant for chlorous acid is 1.1 x 1 o-2. That is:
1 1 X 10-2 = IH ~ ICl02l where the hydrogen ion concentration, [H+], jS the quantity already determined by ionization of the known amount of the carboxylic acid, HA. This calculation is well-known to those skilled in this art.
The oral hygiene compositions of this invention provide a metastable chlorous acid composition formed from relatively small amounts of chlorite and acid.
This composition is capable of generating chlorine dioxide over a long period of time at continuing levels of effectiveness. AS chlorine dioxide forms, more of the chlorite converts to chlorous acid by interacting with hydrogen ions further generated byionization of the carboxylic acid.
The orai hygiene compositions of this invention are therefore different from many prior art chlorine dioxide generating compositions which consist of B ~
~ 339066 relatively high concentrations of chlorite and acid. Prior art chlorine dioxide-containing compositions were not used as mouthwashes or toothpastes and result in the rapid conversion of chlorous acid to chlorine dioxide. The rate of chlorine dioxide formation 5 depends on the sum of the square of chlorous acid concentration and the prdduct of chlorous acid and chlorite concentrations according to the equation:
d[Cl~2] = Kl[HCl02] + k2 [HCl02] [C102]
dt See Gordon, "The Chemistry of Chlorine Dioxide," Pro~. Inor~. Chem. 15:201 (1972).
10Thus the rate at which chlorine dioxide forms depends exponentially on the amount of chlorite ion which is converted to chlorous acid and the amount of chlorite ion present.
In certain embodiments of the invention, the chlorous acid generating composition comprises an aqueous solution containing generally from about 0.01 to 15about 1, typically from about 0.02 to about 0.5, and preferably from about 0.03 to about 0.3 percent by weight of metal chlorite and a suitable amount of an organic acid having a pK of from about 2.8 to about 4.2. The pH of this composition is generally less than about 7, typically from about 2.2 to about 7Ø
In yet another embodiment of this invention, even lower concentrations 20 of chlorite and acid may be used in the composition. These compositions comprise an aqueous solution containing generally up to about 0.4, and typically from about 0 0001 to about 0.03 percent by weight of metal chlorite, and a suitable amount of acid having a pK of from about 2.8 to about 4 2.
B' -14a-The pH of the composition is generally less than about 7, typically from about 2.2 to about 7Ø
In certain embodiments of the invention, the carboxylic acid is an alpha-5 hydroxy carboxylic acid. In preferred embodiments, the alpha-hydroxy carboxylic acid.
has the structure of Formula I herein.
Optionally the compositions of the invention may contain either a suitable amount of a compound containing vicinal hydroxy groups or an amount of a water-soluble chloride in a significant molar excess to the chlorite, or both. These optional 10 ingredients may facilitate the .~
~.
formation of chlorine dioxide from chlorous acid and are thus userul in rapidly disinfec~ing compositions where an, increased rate of chlorine dioxide formation is desired while maintaining a low concentration o~ chlorite and acid.
~'he metal chlorite useful in the present composition may more generally be described as a chlorine dioxide liberating compound. By "chlorine dioxide liberating compound" is meant any compound which, when appropriately treated, e~fects the production of chlorine dioxide as a result of a change in the va]ence state of the chlorine atom from +3 to +4. While any chlorine dioxide liberating compound may be used, water-soluble chlorites are preferred because they are readily available and inexpensive. Typical water-soluble chlorites include metal chIorites, such as alkali metal chlorites and alkaline earth metal chlorites. Sodium chlorite and potassium chlorite are preferred. Sodium chlorite is particularly prererred.
The flavoring agents useful in the compositions of this invention include any flavoring agent or mixture of flavoring agents acceptable in oral hygiene compositions.
Such flavoring agents are well-known to those skilled in this art and include l-carvone (mint flavor), peppermint oil, aspartame, saccharin, wintergreen oil, cinnamon oil, clove oil, menthol, thymol, euca]yptol, oil of sassafras, oil of anise, dextrose and levulose, and other flavoring agents well-known to those skilled in this art.
The term "oral hygiene compositions" is meant to include any composition which is used in the mou~h in order to promote oral hygiene. These compositions may be in the form of a mouthwash, toothpaste, chewing gum, lozenge, or the like.
These compositions may be in the form of a4ueous solutions, as in a mouthwash composition, geLs, as in toothpaste or dentrifice compositions, solids, as in lozenges, or combined with fillers, as in chewing gum composition.
The composition of this invention may contain other additives such as chelating agents (e.g., Na4EDTA), or preservatives (e.g., sodium benzoate). The identity and amount of the other additives will depend upon the type of oral hygiene 5 composition and its end use. Such additives are well-known to those skilled in the art.
Suitable penetrants, astringents, deodorants, and other therapeutic or preventive compounds may be added. Dentrifices or toothpaste compositions according to the invention may also contain humectants, binders sudsing agents, abrasive polishing materials, and thickening agents.
The amount of chlorine dioxide liberating compound that may be used in this composition may be generally from about 0.01% to about 1%, typically from about 0.02% to about 0.05%, and preferably from about 0.03% to about 0.3% by weight of the total composition (including the application medium).
At chlorite ion levels higher than about 0.5%, the concentration of 15 chlorous acid formed upon admixture of a carboxylic acid may be in excess of that required for the formation of a metastable chlorous acid solution. These higher concentrations of chlorous acid would cause the formation of chlorine dioxide, through the degradation of chlorous acid at too rapid a rate.
Any acid of low toxicity may be used in the compositions of the invention 20 so long as the chlorite ion concentration limits described above and the degree of conversion to chlorous acid are met. Carbonic acid may be used as the acid, however preferably carboxylic acids are used. Preferred carboxylic acids include salicylic acid as well as citric, malic, tartaric, glycolic, mandelic or other structurally similar acids as described in Formula I hereinabove.
B
-16a-The pK of these carboxylic acids may be generally from about 2.8 to about 4.2, and preferably from about 3.0 to about 4Ø
The amount of carboxylic acid used in these compositions should be 5 sufficient to lower the pH of the composition to less than about 7, typically from about 2.5 to about 6, and preferably Irom about 3.0 to about 5Ø
Furthermore, this amount may be generally from about 0.01%
to about 3%, typically from about O.S~ to about 2-~o 1. and preferably from about 0.1~ to about 1~o by weight of the total composition (including the application medium).
The amount of flavoring agent useful in this invention may vary widely but is generally from about 0.01 to about 5, typically from about 0.02 to about 2 ~ and preferably from about 0.05 to about 1 percent by weight based upon the total weight of the composition.
A suitable amount of a vicinal dihydroxy or polyhydroxy compound may also be added to the compositions of the present invention. The use of such compositions enables one to produce compositions according to the invention which are more rapidly effective in higher pH
ranges. The use of these vicinal dihydroxy or polyhydroxy compounds also allows for the use of compositions according to the invention which contain a much lower acid concentration than that which is needed if the vicinal polyhydroxy compound comprising at least two vicinal hydroxy groups is absent.
Vicinal polyhydroxy compounds which contain at least two vicinal hydroxy groups are well-known to those skilled in this art and include dextrose and other sugars, glycerin, sorbitol, and inositols. In other embodiments, sugars with vicinal hydroxy groups in the cis configuration such as galactose, mannose, and ribose may be used.
The use of such vicinal polyhydroxy compounds, particularly those with cis-vicinal hydroxy groups, in conjunction with the chlorine dioxide liberating compound and carboxylic acid results in a synergistic composition.
The vicinal dihydroxy or polyhydroxy compound catalyzes the formation of chlorine dioxide from chlorous acid. For example, the rate of formation of the active chlorine dioxide entity using a composition comprising sodium chlorite and mandelic acid is substantially enhanced by the addition of a relatively insubstantial amount of a vicinal polyhydroxy compound. Thus, the use of as little as 0.1 ribose in the composition substantially enhances the rate~
of formation of the active entity vis-a-vis a composition containin~ only sodium chlorite and one of the organic acids discussed hereinabove.
Stated otherwise, a composition containing the vicinal polyhydroxy compound may be prepared having substantially the same initial germ-killing efficacy in a specified time period as a composition which does not contain the vicinal polyhydroxy compound even though the composition containing the polyhydroxy compound contains substantially much less organic acid and sodium chlorite.
Elowever, such activation of the system results in a more rapid depletion of the chlorite ion in the composition, so that the germ-k-illing activity at a ]ater time period would-be less. The vicinal polyhydroxy compounds may also serve - another purpose in the composition in that it may act as a sweetener or enhance the solubility of the flavoring-agents.
lhe amount of vicinal polyhydroxy compound containing at least two vicinal hydroxy groups may vary widely, but in the present invention there is employed generally less than about 20%, typically ~rom about 0.1% to about 10%, and preferably from about 0.2% to about ~% by weight of the total composition.
Alternatively, or in addition, the composition may contain a large excess of chloride ion in the form of an alkali or an alkaline earth metal salt. The excess may be from about a 10 to about a 100-fold excess by weight of chloride ion of total chlorite ion concentration. Large excesses of chloride ion in acid solutions (below a pH of about 7) cause the chlorite ion to decompose in an accelerated manner, via the formation of chlorous acid to form chlorine dioxide. In a preferred embodiment of the invention where rapid disinfection is required, the composition contains both a high excess o~ chloride ion and 1 33qo66 a sufficient amount of vicinal polyhydroxy compound comprising at least two vicinal hydroxy groups.
The chlorine dioxide liberating compound is generally kept separate from the organic acid prior to use in order to avoid premature reaction of the ingredients.
l'he flavoring agent may be combined with either the organic acid or the chlorine dioxide liberating compound, or both, prior to their admixture.
The oral hygiene compositions of this invention result in improved bactericidal, fungicidal, virucidal and taste properties over presently available commercial oral hygiene compositions and aid in den~al plaque reduction.
The present invention also provides a process for -- producing d;sinfectant oral hygiene compositions. This process comprises admixing: (a) a flavoring agent acceptable for oral hygi~ne compositions, (b) from about 0.03% to about 0.3~ by weight of chlorine dioxide liberating compound based upon the total weight of the composition, and (c) a suitable amount of an organic acid which as a pK of from about 2.8 to about 4.2. The composition contains substantia~]y no lactic acid.
The present invention also provides a process for reducing -dental plaque as well as controlling gingivitis and periodontitis in the mouth. This process comprises treating the mouth with an oral hygiene composition. The composition comprises (a) a flavoring agent acceptable for use in the mouth, (b) from about 0.03 to about 0.3 of a chlorine dioxide liberating compound based upon the total weight of the composition, and (c) a suitable amount of an organic acid having a pK of from about 2.8 to about 4.2.
The composition contains substantially no lactic acid.
The present invention is il]ustrated by the following examples. Unless otherwise noted, all parts and 3~ percentages in the examples as well as the specification and claims are by weight.
EXAMPrJ~ I
This example illustrates the preparation of a , toothpaste composition according to the present invention.
There is prepared a two-part disinfectant toothpa~te composition according to the invention having a first base paste or gel and a second ac~ivator paste or gel.
The formulations of the two toothpaste parts on a percent weight to weight basis are as follows:
TOOTHPASTE
BASE % W/W
Poly(sulionic Acid) l16~ aqueous solidsl 45.0 Sodium hydroxide, lN 40.0 Bentonite 2.0 15 Sodium lauryl sulfate 1.0 Titanium dioxide 1.0 Silica, amorphous 0.5 Sodium chlorite l.0 Water q.s 20 ACTIVA'rOR
G]ycerin l0.0 Magnesium a]uminum silicate 5.0 Hydroxyethylcellulose 2.0 Malic acid 1.5 Flavor, wintergreen 0.4 FD&C Blue #1 (0.5% solution) 0.06 Sodium benzoate 0.05 25 sodium saccharine Water q.s The p~l of the composition resulting from the mixture of substantially equal portions of ~he base and activator gels of the above formulation is about 4.15.
The base gel and the activator gel are preferably stored separately prior to use, e.g., in a double-compar~-ment tube. The two g~ls are mixed, preferably just prior to use, in substantially equal amounts and the mixture is used in the normal manner as a toothpaste. Alternatively, substantially equal portions of the gels are placed in the mouth and mixed by the brushing action while the subject brushes his or her teeth.
EXAMPLE II
This example iLlustrates the use of the present invention as a teat dip for application to cow udders.
~ first gel is prepared by mixing the following ingredients:
]0 Rheothik~80-ll poly(sulfonic acid) i]6% aqueous solidsJ l6.00%
NaOH, lN 16.Q0 Naconnol*90F (sodium dodecylbenzene sulfonate~ 1.80~
Sodium chlorite 0.64%
Na~FDTA 0.19%
~ Sil~T-600 (silica) 2.50-~z 15 Water q.s.
A second gel is prepared by mixing the following ingredients:
20 I.actic acid 2.6~%
Natrosol 250MR 1.00%
Isopropyl alcohol 2.00%
Sodium benzoate o.o~%
Po3oxamer~188 0.40%
FD&C Yellow #5 0 30%
Water q.s.
The two solutions are blended, preferably just prior to application. The resulting gel is applied to the cow teat, forming a solid shield around the teat. The film thus formed, following drying, provides a long-lasting and continuously acting disinfectant in direct contact with the skin surface.
EXAME'LE III
l'his example illustrates the preparation of a topical gel useful for the treatment of infection-based facial acne.
A first gel is prepared by mixing the following-ingredients:
~n Rheothik 80-ll poly(sulfonic acid) l16~ aqueous solids~ 45.00Oz NaOIl, lN 38.00 Naconnol 90F l.80%
Na4E~TA 0.19%
NaClO2 2.50%
Deionized water q.s.
A second gel is prepared by mixing the following ingredients:
Salieylie aeid 2.00~
Isopropyl alcohol 30.00%
Sodium benzoate o.o~%
Natrosol~250MR 2.10%
P~uronic~-68 0.~0%
Deionized water 65.46%
l'he first and second solutions are mixed, preferably just prior to use. The resulting gel is applied to the a~fected region of the skin. A film forms, creating a long-lasting eover that provides a continuous supply of disin~ectant to the covered area of skin for a prolonged period of time.
EXAMI'LE ~V
This example illustrates the properties of compositions employing hydroxyethyl cellulose as a gelling ager-t for sodium chlorite in the preparation of a final composition comprising sodium chlorite and ]act;c acid.
Example I is repeated, but hydroxyethyl cellulose is used at the 2~ level in place of the polysulfonic acid salt and excluding ~he sodium hydroxide. This gel is not storage stable for a commercially acceptable period of time.
l'he cellulose gelling agent depolymerizes and loses viscosity.
EXAMPLE V
This example illustrates the preparation of a mouthwash according to the present invention.
A first solution is prepared by dissolving 0.4 grams of technical grade sodium chlorite, 0.17 grams of powdered Na4EDTA 4l~2O, 0.5 grams of l-carvone (mint flavor), and the appropriate amount of a compatible food grade yellow dye in 500 milliliters of aqueous solution. A
second solution is prepared by dissolving 1.375 grams of anhydrous citric acid and the appropriate amount of E'D&C
Blue #1 in a batch of 500 milliliters of a ]0 percent by weight aqueous solution of glycerin.
The two solutions are mixed, preferably just prior to use, in substantially equal amounts and the mixture is used in the normal manner as a mouthwash.
EXAMPLE VI
This example also illustrates the preparation of a mouthwash according to the present invention.
A first aqueous solution o~ 0.25% sodium chlorite and 0.10% NaOI~ in deionized water is prepared.
A second aqueous activator solution is prepared of 0.75% malic acid, 10.00% glycerine USP, 0.05% sodium benzoate, 0.50% Equal (aspartame diluted with dextrose and corn syrup solids), 0.03% FD~C Blue #1 (0.3% solution), and 0.40% Wintergreen Flavor (BBA),- in deionized water.
The two solu-tions are mixed, preferably just prior to use in substantially equal amounts, -and the mixt~re is used in the normal manner as a mouthwash.
EXAMPLE VII
This example illustrates the ability o~ a composition of the present invention to reduce dental plaque and control gingivitis and periodontitis.
Mouthwash compositions according to the invention were used in a five day triple-crossover plaque reduction test. In this test, 18 human subjects were divided into three groups of six subjects each. The teeth of each subject were scraped free of plaque immediately prior to the commencement of each five day period.
Each group was subjected to three five day periods of treatment with the following formulations:
(a) placebo, (b) low potency mouthwash formulation, and (c) high potency mouthwash formulation. The sequence of the treatments per group were selected in a random fashion.
During the tive day period the subjects rinsed with the formulation twice daily, i.e., in the morning and afternoon.
The subjects did not brush their teeth or perform any other oral hygiene procedures. The same treatment procedure was followed ~or all three of the formulations. Plaque scores after each five day period were determined by a modified Quigley-Hein index.
The placebe was formulated so that it had substantially the same perceived acidity as the other two formulations. The placebo formulation comprised an aqueous so]ution of 0.27% citric acid, 0.08% sodium chloride, 0.5%
l-carvone, 0.09~z FD&C Green #3 (5000 ppm solution), 0.03%
ED&C YelLow #5 (5000 ppm solution), and 5.0% glycerin.
The compositions were formulated in two parts, A
and B. Equal volumes of the two parts were mixed immediately before rinsing. The percent compositions o~
parts A and B of the high potency and ]ow potency formulations were as follows:
INGREDIENT IIIGH POT~NCY LOW POTENCY
Part A
Sodium chlorite (79~) 0.32 0.08 l-Carvone 0.10 0.10 ED&C Green #3 (5000 ppm solution) 0.18 0.18 1 N Sodium hydroxide q.s. q.s.
Part B
Malic acid 0.75 0.275 Sodium benzoate 0.05 0.05 Glycerin 10.00 10.00 FD&C Yellow #5 (5000 ppm solution) q.s. q.s.
The average plaq~le scores of the subjects listed below show that the mouthwash compositions of this invention were effective in substantially reducing dental plaque.
Score (average) ~ Reduction Placebo 3.82 ---Low potency 3.35 12.3 lligh potency 2.47 35.3 EXAMPLE VIII
An evaluation was made of the microbiocidal effectiveness of the High Potency mouthwash (0.32% Sodium chlorite - Part A; 0.75% Malic acid - Part B) in Example VII, versus that of 0.2% chlorhexidine digluconate. The 0.2% Chlorhexidine digluconate solution is the recommended reference standard by which other oral hygiene germicides should be measured. The procedure employed was based on the method in the F~A OTC Oral E3ealth Care Monograph (Federal Register, Vol. 47, No. 10l, May 25, 1982, pages 22890-22900). The test organisms were:
Candida albicans ATCC 18804 (American Type Culture Collection, Rockville, Md.) Actinobacillus actinomycetemcomitans Forsyth Clinic Isolate #Y4 Streptococcus mutans ATCC 25175 The microorganisms were grown in Brain ~leart Infusion, and subcultured for two successive days at 37~C.
Two ml of a 50:50 mix of each test organism in sterile fetal calf serum was added to 8 ml of the mouthwash formulation, and triplicate aliquots of the inoculated test formulation were removed at 30 and 60 second for subculture.
C. albicans was grown and subcultured aerobically; all other organisms, anaerobically. The ~igh Potency test solutions were neutralized first in fluid thioglycolate medium, and ~urther neutra]ized in the plate count agar.
The chlorhexidine digluconate control solutions were only neutralized in the enumeration agar. Results obtained were as ~ollows:
Average Microbial Test Log Reduction*
Formulation Organism 30 Sec. Exp. 60 Sec. FJXP.
Iligh Potency C. albicans 3.2 3.0 Actinobacillus 7.5 7.5 Strep. mutans 3.5 4.3 Chlorhexidine C. albicans 3.2 3.3 digluconate, 0.2~ Actinobacillus 6.6 6.3 Strep. mutans 3.0 3.0 *Average of three results.
The High Potency Formulation shows a microbiocidal efficacy equal to or greater than of chlorhexidine digluconate at the 0.2% level.
These microbiocidaL data strongly indicate that these formu]ations will not onl,y be helpful in reducing dental plaque formation, but also would inhibit the onset and severity of gi,ngivitis and other associated oral disorders such as periodontitis which could lead to eventual tooth loss.
' The principles, preferred embodiments, and modes of operation of the invention have been described in the foregoing specification. I~owever, the invention herein which is intended to be protected, is not to be construed as limi~ed to the particular forms disclosed, since these are to be regarded as illustrative rather than restrictive.
Variations and changes may be made by those skilled in the art without departing ~rom the spirit of the invention.
This is a divisional application of Application Serial No. 563,942.
Technical Field This invention relates generally to compositions for disinfecting substrates as well as to processes for preparing and using such compositions. Further, this invention relates to disinfecting compositions useful as oral hygiene compositions such as a mouthwash, toothpaste, lozenge, chewing gum, or the like.
Background of the Invention The term "disinfectant" is used in this specification to broadly include any substance or composition that disinfects, sanitizes, deodorizes, sterilizes, or kills germs.
The use of chlorine compounds in various types of disinfectant compositions is well known. Chlorine compounds suggested for use in this regard include, for example, sodium hypochlorite, used in World War I was a wound irrigant, and chlorinated phenols, such as m-chlorophenol. These compounds have increased bactericidal activity and reduced toxicity, in some instances, when compared to non-chlorinated phenols. Thus, m-chlorophenol has a phenol coefficient of 5.8 (S. aureus) to 7.4 (B. typhosus). Other chlorine compounds having some form of disinfectant utility include, for example, chlorine gas itself, chlorine dioxide, chloramine T, calcium hypochlorite (a standard swimming pool disinfectant), chloropicrin (a larvicide), chloroform (a fumigant), chlorodane (an insecticide), and chloromycetin (an antibiotic).
Chlorine dioxide in particular has been found to be an especially effective disinfectant. This compound is quite versatile and has long been used as a bleaching agent, such as in the oxidizing of the natural colorant *
present in cotton, wood pulp and other cellulosic fibrous material. In such uses, chlorine dioxide, though perform- t ing an oxidizing function, is nevertheless noninjurious with respect to the fibrous material.
Particularly useful disinfecting compositions which employ chlorine-containing compounds are disclosed in U.S. Patent Nos. 4,330,531 and 4,585,482. These composi-tions comprise chlorite salts, such as sodium chlorite, in combination with weak organic acids, such as lactic acid, to provide particularly effective disinfectant compositions.
These compositions are useful in topically treating skin diseases such as acne and in toothpastes.
One particularly preva]ent disease is mastitis in dairy herds. Mastitis is a highly infectious disease which affects the bovine udder. l'he losses in dairy production resulting from this disease are staggering. For example, in the United States alone, these losses are estimated to be in the hundreds of millions of dollars. Mastitis not only reduces the production of higher yielding animals, but also shortens their productive life.
It is well known that mastitis is transmitted from animal to animal. It has also been established that the only route of transmission of the disease is through the teat orifice. Conditions which are help primarily responsible for the high incidence of mastitis include poor udder hygiene and physical damage to the teats. Dairymen and veterinarians have long sought a conditioning and protective composition which is economical and also provides facility of use. A composition which would improve the normal condition of the udder and teats and would also aid in preventing or effectively reducing the incidence of mastitis would serve to substantially increase both the production and productive life of a dairy herd.
Infectious mastitis is caused by microorganisms.
Prior art treatments, such as the use of sulfanilimide, have been only partially effective in controlling the disease because such treatments are useful against only one type of microorganism which causes mastitis but are not useful against other types. Since the infection is usually of a mixed character, it fol~ows that the ef~ectiveness of drugs such as sulfanilimide is limited for all practical purposes.
It has also been suggested to use penicillin for the treatment of mastitis. The use of this compound is not desirable, however, in view of the high cost and extraordi-nary conditions necessary for the preservation and use of penicillin It has been proposed in U.S. Patent No. 3,222,252 to treat mastitis with a preparation which comprises a - blend of edible, semidrying oils and drying oils together with a fatty acid ester, skin emollient, film-forming agent.
It is said that the presence of a drying oil in the prepara-tion is essential to provide the desired ~ilm-forming property. But for the most part, these film-forming-based treatments of mastitis have been unsuccessful. The use of iodine and peroxide in conjunction with latex emulsion films has led to other problems, including milk contamina-tion and skin irritation.
While chlorine-liberating compounds have germicidal and deodorant properties, their characteristic taste and odor make them unpleasant for use in oral hygiene compositions such as mouthwashes. Other oral hygiene compositions, some commercially avai]able, while pleasant tasting, are ineffective to reduce dental plaque as well as control gingivitis and periodontitis.
The search has continued for new and improved oral hygiene compositions which are both pleasant tasting and effective in reducing dental plaque as well as control gingivitis and periodontitis. This invention was made as a result of that search.
The use of compositions comprising metal chlorite and a weak organic acid, such as lactic acid, is disclosed in U.S. Patent No. 4,330,531. A chlorine dioxide releasing compound offers to substantially alleviate the problems associated with the prevention of mastitis. For this, application, the use of a gelling agent to generate a viscous topical gel is essential. The viscosity is needed for proper adhesion to the skin surface for an extended length of time.
Past attempts to create a useful viscous topical gel containing chlorine dioxide releasing compounds have been less than completely successful. Of the gelling agents tried, none combined the properties needed for substantial effectiveness.
Carbohydrate-based gels lose their viscosity at higher pH's as the alkaline chlorites break down the long polymer chains.
Inorganic thickeners, such as bentonite clays, participate in the reaction between the acid and chlorite, and tend to form stringy, unsuitable gels.
The search has continued for a viscous topical gel composition capable of embodying alkaline chlorites for the treatment and prevention of skin disease, infection and irritation on humans and other ~n;m~ls. This invention was made as a result of that search.
Obiects and Summary of the Invention Accordingly, it is a general object of the present invention to avoid or substantially alleviate the above-identified problems of the prior art.
Another object of the present invention is to provide improved oral hygiene compositions useful in reducing dental plaque.
A further object of the present invention is to provide oral hygiene compositions which are pleasant tasting yet effective to reduce dental plaque and control gingivitis and periodontitis.
An additional object of this invention is to provide, a method for producing these oral hygiene compositions.
Yet another object of this invention is to provide a method for disinfecting the mouth comprising treating the mouth with these oral hygiene compositions.
Other objects and advantages of the present invention will become apparent from the following summary of the invention and description of its preferred embodiments.
The present invention provides, in one aspect, a disinfectant oral hygiene composition for reducing dental plaque.
This composition comprises: (a) a flavouring agent acceptable for oral hygiene compositions, (b) an aqueous solution containing a suitable amount of an acid, and (c) an amount of a metal chlorite such that the chlorite ion concentration in the form of chlorous acid is no more than about 15 percent by weight of the total amount of chlorite ion concentration. The composition contains substantially no lactic acid.
In another aspect, the present invention provides a process for producing these disinfectant oral hygiene compositions. This process comprises admixing (a) a flavouring agent acceptable for oral hygiene compositions, (b) from about 0.03 to about 0.3 percent by weight of a chlorine dioxide liberating compound based upon the total weight of the composition, and (c) a suitable amount of an organic acid having a pK of from about 2.8 to about 4.2. The composition contains substantially no lactic acid.
In yet another aspect, the present invention provides a disinfectant oral hygiene composition for reducing dental plaque and controlling gingivitis and periodontitis, which composition comprises: (a) a flavouring agent acceptable for oral hygiene compositions, (b) from about 0.03 to about 0.3 percent by weight of a chlorine dioxide liberating compound based, upon the total weight of the composition, and (c) a suitable amount of an organic acid having a pK of from about 2.8 to about 4.2. The composition contains substantially no lactic acid.
In a further aspect, the present invention provides a composition comprising an aqueous solution or gel containing a suitable amount of a protic acid with an amount of a metal chlorite such that the chlorite metal ion concentration in the form of chlorous acid is no more than about 15 percent by weight of the total amount of chlorite ion concentration, the composition containing substantially no lactic acid.
There is also provided a disinfectant oral hygiene composition for reducing dental plaque which comprises a flavouring agent acceptable for oral hygiene compositions, an aqueous solution containing a compound which contains at least two vicinal hydroxy groups, a suitable amount of a protic acid, and an amount of metal chlorite such that the chlorite ion concentration in the form of a chlorous acid is no more than about 15 percent by weight of the total amount of chlorite ion concentration. The composition contains substantially no lactic acid.
1 339~66 The disinfecting compositions of this invention disinfect by means of a chlorous acid generating, composition. The composition comprises a flavoring agent, suitable amount of a carboxylic acid, and a suitable amount of a metal chlorite. The chlorite ion concentration in the form of chlorous acid is no more than about 15 5 percent by weight of the total amount of chlorite ion concentration.
The oral hygiene formulations of this invention contain low concentrations of chlorous acid generating compounds which are extremely effective as oral disinfectants. These compositions provide effective mouthwashes, toothpastes and other oral disinfecting compositions without the strong characteristic unpleasant taste 10 of chlorine.
DETAILED DESCRIPTION OF THE INVENTION
The composition of this invention is formed by combining one gel which comprises a dilute aqueous solution of metal chlorite with another gel which comprises a dilute aqueous solution containing a weak organic acid. The gel containing the metal 15 chlorite also contains the polysulfonic acid salt. The concentrations of chlorite and acid are relatively low.
This composition provides a metastable chlorous acid composition formed from small amounts of chlorite and acid. This composition is capable of generating chlorine dioxide over a long period of time at continuing levels of effectiveness.
'~, ~l,, As chlorine dioxide forms, more of the chlorite converts to chlorous acid by interacting with hydrogen ions further generated by ionization of the organic acid.
Weak organic acids which may be used in the present invention include 5 salicylic acid as well as citric, malic, tartaric, glycolic, mandelic and other structurally similar acids as described in Formula I hereinbelow:
FORMULA I
C-OH
R - C - OH
R' and R2 may be the same or different and may be selected from the 10 group consisting of hydrogen, methyl, -CH2COOH, -CH2OH, - CHOHCOOH, -C6H5 and -CH2C6H5. The pK of the organic acid is from about 2.8 to about 4.2, preferably from about 3.0 to about 4Ø
Compositions of a metal chlorite and the weak organic acids of Formula I are disclosed in United States Patent No. 4,986,990.
The gel containing the protic acid also contains a gelling agent or thickener which is well known to those skilled in this art. Any gelling agent or thickener which is nontoxic and nonreactive with the other ingredients of the composition may be used, such as cellulose gels, typically methyl cellulose, or preferably, hydroxy ethyl cellulose.
B
-8a-Furthermore, that gel may also contain a preservative, such as benzyl alcohol orsodium benzoate. Other additives, such as buffers to adjust the pH of the composition to become more compatible with the skin, may be used.
The amount of thickener in the protic acid-containing gel may be generally from about 0.5% to about 5%, typically from 0.8% to about 4%, and preferably from about 1% to about 3% of the gel, by weight, of the total composition. The amountof preservative in the gel may be generally from about 0.01% to about 0.05%, typically from about 0.01% to about 0.04%, and preferably from about 0.02% to about 3%, by weight, of the total composition.
The chlorine dioxide liberating compound or metal chlorite and the protic acid are present in separate gels, and the amount of the preservative is present in only that .~
1 33qo66 gel containing the protic acid. Approximately equal amounts of the separate gels should be used.
The gel containing metal chlorite is thickened with a -~lysulfonic acid salt. The amount of polysulfonic acid salt added will depend on the desired use of the resulting composition. For a topical cream, toothpaste, or topical gel for the treatment of facial acne, the amount of the thickener in the metal chlorite-containing gel may be generally from about 5% to about 15%, typically from about 5% to about 10%, and preferably from about 6% to about 8%, by weight, polysulfonic acid salt based upon the total composition. For a composition particularly suited to be used as a teat dip for treating cow udders, the amount of thickener in the metal chlorite-containing gel may be generally from about 0.5% to about 5%, typically from about 1% to about 4%, and preferably from about 2% to about 3%, by weight, solid polysulfonic acid salt based upon the total composition.
These polysulfonic acid salts are polymers of 2-acrylamido-2-methylpropane sulfonate. The preparation of such polymers is described in U.S. Patent No. 4,128,631, Canadian Patent No. 864,433, and German OLS No. 2,153,292, laid open May 4, 1972.
The pH of the gel containing the polysulfonic acid is generally greater than about 8, typically from about 9 to about 12, and preferably from about 10 to about 11.5.
The polymers useful in the present invention are prepared from:
O
CH2=CH-C-NH-C( CH2 ) -CH2S03H
or a salt thereof. The polymerization reaction may be accomplished by solution, emulsion, or suspension polymerization processes. The medium for the polymerization is conveniently water, an alcohol, or a mixture thereof. The choice of medium is best dictated by the requirements of the final composition to be formulated.
The polymerization reaction is temperature-, pll-and catalyst-sensitive. ln addition, it is desirable to exclude oxygen from the reaction vessel used to form the polymer, as that material inhibits the polymerization process. The catalysts which are included to enhance the rate of polymerization are materials such as ammonium bisulfite, ferrous sulfate, hydrogen peroxide, sodium metabisulfite, or other redox catalysts.
The polymer may be varied in molecular weight by controlling the amount of the cata]yst, the pll, or the rate of addition of the monomer to the reaction vessel. The polymerization may be faci]itated by converting the monomer from its acid form to a salt which is water-soluble.
The salts o~ the polymer preferably contain as cations, sodium, potassium ammonium, monethanolamine, diethanolamine, triethanolamine, and 2-amino-2-methyl-1-propanol as we]l as mixtures thereof. The foregoing list is merely exemplary of water-soluble salts which may be used. Also within the scope of the present invention are water-insoluble salts wherein the final composition is not adversely affected by precipitation of the polymer. Such products in which water-insoluble salts of the polymer may be utilized are toothpastes, or substan~ially nonaqueous products such as topical creams.
As was previously mentioncd, the molecular weight of the polymer may be controlled by the pll, the rate of addition of the monomer, or the judicious use of the cata-lyst. It has been found desirable to utilize the afore-described polymers having a molecular weight of from about 1,000,000 to about 5,000,000, more preferably from about 2,500,000 to about 4,500,000, to improve the viscosity and film-forming characteristics of the composition. That is, extremely high molecular weight polymers of the type described may result in a pituitive or stringy consistency of the end product. It has therefore been found desirable to limit the pituitiveness by selecting the preferred mole-cular weight range. To this end, any common chain transfer agent, such as mercaptosuccinic acid, may be used to limit the molecular weight of the polymer.
It is noted that the terminal groups on the polymer have little bearing on the desired properties of the final composition and are thus not specified. The terminal groups are most often hydrogens, but may also be hydroxyl, sulfate, sulfonate, or:
o ~t -CH2=CI~-C-NE~2 All alcohols, particularly the monhydric alcohols, may be used as ingredients with the polymer.
Alcohols (Cl-C2~) which are nonirritating to the skin, such as methanol, ethanol, isopropanol, propyl, lauryl, myristyl, cetyl, and stearyl, as well as mixtures thereof, are preferred. Polyols such as glycerine, or ethylene glycol or propylene glycol may be utilized advantageously with the polymer. The choice of the alcohol to be utilized with the particular polymer of the composition o~ the present invention will ordinarily be dictated by product aesthetics and the physical form of the composition. For instance, when liquid compositions are desired, the lower alcohols are preferably utilized, while cream compositions within the scope o~ the present invention will normally require the higher alcohols. Where the compositions of the present invention contain ingredients other than the polymer or the alcohol in substantial amounts, the choice of the particular alcohol becomes less important.
A desirable variable of the present invention is the incorporation of water with the polymer. A resuLtant increase in viscosity of the water is noted with no adverse effects on the stability of the product; that is, water is a highly suitable carrier which may be used as a vehicle for contacting the polymer and the substrate. The parti-cular weight ratios at which the desirable increase in - viscosity occurs for mixtures of the polymer and water are respective~y from about 1:10,000 to about 1:100. ~refer-ably this ratio is in the range of from about 1:1000 to about 1:500. Within the aforementioned range, highly - 5 viscous compositions are obtained with low solids content.
Such compositions are desirable in that they allow eomposi-tions such as topical creams or gels, acne gels, or teat dips to be formulated in a thickened state, providing greater ease of application.
~'he gel containing the protic acid and the gel containing the metal chlorite are mixed either before appli-cation to the affected substrate or preferably in situ.
After the gels are mixed, the pl~ of the final composition is generally less than about 7, typically from about 2 to about 5, and preferably from about 2.5 to about 4.
In the present invention, the composition is ordinarily used at a level of about 0.001 gram per square centimeter to about 0.1 gram per square centimeter of the affected substrate.
The oral hygiene compositions of this invention comprise a flavoring agent suitable for use in an oral hygiene composition, a suitable amount of a carboxylic - acid, and a suitable amount of a metal chlorite. The concentrations of chlorite and acid are relatively low and are such that the amount of chlorite in the form of chlorous acid is no more than about 15 percent by weight of the total chlorite ion concentration in solution.
Typically the amount of the chlorite in the form of chlorous acid is nor more than about 10 percent by weight of the total chlorite ion concentration in solution.
The percent by weight of chlorite and chlorous acid may be calculated from the ionization constant of chlorous acid and the amount of hydrogen ion in solution produced by the partial ionization of the carboxylic acid.
Thus the hydrogen ion concentration, IH+I, in a solution of the carboxylic acid, HA, of known molar concentration and whose ionization constant is KA~ may be calculated from the following relationship:
KA = [H+1 [A~]
[HA]
This same relationship may be applied to calculate the relative chlorite and chlorous acid concentrations where the ionization constant for chlorous acid is 1.1 x 1 o-2. That is:
1 1 X 10-2 = IH ~ ICl02l where the hydrogen ion concentration, [H+], jS the quantity already determined by ionization of the known amount of the carboxylic acid, HA. This calculation is well-known to those skilled in this art.
The oral hygiene compositions of this invention provide a metastable chlorous acid composition formed from relatively small amounts of chlorite and acid.
This composition is capable of generating chlorine dioxide over a long period of time at continuing levels of effectiveness. AS chlorine dioxide forms, more of the chlorite converts to chlorous acid by interacting with hydrogen ions further generated byionization of the carboxylic acid.
The orai hygiene compositions of this invention are therefore different from many prior art chlorine dioxide generating compositions which consist of B ~
~ 339066 relatively high concentrations of chlorite and acid. Prior art chlorine dioxide-containing compositions were not used as mouthwashes or toothpastes and result in the rapid conversion of chlorous acid to chlorine dioxide. The rate of chlorine dioxide formation 5 depends on the sum of the square of chlorous acid concentration and the prdduct of chlorous acid and chlorite concentrations according to the equation:
d[Cl~2] = Kl[HCl02] + k2 [HCl02] [C102]
dt See Gordon, "The Chemistry of Chlorine Dioxide," Pro~. Inor~. Chem. 15:201 (1972).
10Thus the rate at which chlorine dioxide forms depends exponentially on the amount of chlorite ion which is converted to chlorous acid and the amount of chlorite ion present.
In certain embodiments of the invention, the chlorous acid generating composition comprises an aqueous solution containing generally from about 0.01 to 15about 1, typically from about 0.02 to about 0.5, and preferably from about 0.03 to about 0.3 percent by weight of metal chlorite and a suitable amount of an organic acid having a pK of from about 2.8 to about 4.2. The pH of this composition is generally less than about 7, typically from about 2.2 to about 7Ø
In yet another embodiment of this invention, even lower concentrations 20 of chlorite and acid may be used in the composition. These compositions comprise an aqueous solution containing generally up to about 0.4, and typically from about 0 0001 to about 0.03 percent by weight of metal chlorite, and a suitable amount of acid having a pK of from about 2.8 to about 4 2.
B' -14a-The pH of the composition is generally less than about 7, typically from about 2.2 to about 7Ø
In certain embodiments of the invention, the carboxylic acid is an alpha-5 hydroxy carboxylic acid. In preferred embodiments, the alpha-hydroxy carboxylic acid.
has the structure of Formula I herein.
Optionally the compositions of the invention may contain either a suitable amount of a compound containing vicinal hydroxy groups or an amount of a water-soluble chloride in a significant molar excess to the chlorite, or both. These optional 10 ingredients may facilitate the .~
~.
formation of chlorine dioxide from chlorous acid and are thus userul in rapidly disinfec~ing compositions where an, increased rate of chlorine dioxide formation is desired while maintaining a low concentration o~ chlorite and acid.
~'he metal chlorite useful in the present composition may more generally be described as a chlorine dioxide liberating compound. By "chlorine dioxide liberating compound" is meant any compound which, when appropriately treated, e~fects the production of chlorine dioxide as a result of a change in the va]ence state of the chlorine atom from +3 to +4. While any chlorine dioxide liberating compound may be used, water-soluble chlorites are preferred because they are readily available and inexpensive. Typical water-soluble chlorites include metal chIorites, such as alkali metal chlorites and alkaline earth metal chlorites. Sodium chlorite and potassium chlorite are preferred. Sodium chlorite is particularly prererred.
The flavoring agents useful in the compositions of this invention include any flavoring agent or mixture of flavoring agents acceptable in oral hygiene compositions.
Such flavoring agents are well-known to those skilled in this art and include l-carvone (mint flavor), peppermint oil, aspartame, saccharin, wintergreen oil, cinnamon oil, clove oil, menthol, thymol, euca]yptol, oil of sassafras, oil of anise, dextrose and levulose, and other flavoring agents well-known to those skilled in this art.
The term "oral hygiene compositions" is meant to include any composition which is used in the mou~h in order to promote oral hygiene. These compositions may be in the form of a mouthwash, toothpaste, chewing gum, lozenge, or the like.
These compositions may be in the form of a4ueous solutions, as in a mouthwash composition, geLs, as in toothpaste or dentrifice compositions, solids, as in lozenges, or combined with fillers, as in chewing gum composition.
The composition of this invention may contain other additives such as chelating agents (e.g., Na4EDTA), or preservatives (e.g., sodium benzoate). The identity and amount of the other additives will depend upon the type of oral hygiene 5 composition and its end use. Such additives are well-known to those skilled in the art.
Suitable penetrants, astringents, deodorants, and other therapeutic or preventive compounds may be added. Dentrifices or toothpaste compositions according to the invention may also contain humectants, binders sudsing agents, abrasive polishing materials, and thickening agents.
The amount of chlorine dioxide liberating compound that may be used in this composition may be generally from about 0.01% to about 1%, typically from about 0.02% to about 0.05%, and preferably from about 0.03% to about 0.3% by weight of the total composition (including the application medium).
At chlorite ion levels higher than about 0.5%, the concentration of 15 chlorous acid formed upon admixture of a carboxylic acid may be in excess of that required for the formation of a metastable chlorous acid solution. These higher concentrations of chlorous acid would cause the formation of chlorine dioxide, through the degradation of chlorous acid at too rapid a rate.
Any acid of low toxicity may be used in the compositions of the invention 20 so long as the chlorite ion concentration limits described above and the degree of conversion to chlorous acid are met. Carbonic acid may be used as the acid, however preferably carboxylic acids are used. Preferred carboxylic acids include salicylic acid as well as citric, malic, tartaric, glycolic, mandelic or other structurally similar acids as described in Formula I hereinabove.
B
-16a-The pK of these carboxylic acids may be generally from about 2.8 to about 4.2, and preferably from about 3.0 to about 4Ø
The amount of carboxylic acid used in these compositions should be 5 sufficient to lower the pH of the composition to less than about 7, typically from about 2.5 to about 6, and preferably Irom about 3.0 to about 5Ø
Furthermore, this amount may be generally from about 0.01%
to about 3%, typically from about O.S~ to about 2-~o 1. and preferably from about 0.1~ to about 1~o by weight of the total composition (including the application medium).
The amount of flavoring agent useful in this invention may vary widely but is generally from about 0.01 to about 5, typically from about 0.02 to about 2 ~ and preferably from about 0.05 to about 1 percent by weight based upon the total weight of the composition.
A suitable amount of a vicinal dihydroxy or polyhydroxy compound may also be added to the compositions of the present invention. The use of such compositions enables one to produce compositions according to the invention which are more rapidly effective in higher pH
ranges. The use of these vicinal dihydroxy or polyhydroxy compounds also allows for the use of compositions according to the invention which contain a much lower acid concentration than that which is needed if the vicinal polyhydroxy compound comprising at least two vicinal hydroxy groups is absent.
Vicinal polyhydroxy compounds which contain at least two vicinal hydroxy groups are well-known to those skilled in this art and include dextrose and other sugars, glycerin, sorbitol, and inositols. In other embodiments, sugars with vicinal hydroxy groups in the cis configuration such as galactose, mannose, and ribose may be used.
The use of such vicinal polyhydroxy compounds, particularly those with cis-vicinal hydroxy groups, in conjunction with the chlorine dioxide liberating compound and carboxylic acid results in a synergistic composition.
The vicinal dihydroxy or polyhydroxy compound catalyzes the formation of chlorine dioxide from chlorous acid. For example, the rate of formation of the active chlorine dioxide entity using a composition comprising sodium chlorite and mandelic acid is substantially enhanced by the addition of a relatively insubstantial amount of a vicinal polyhydroxy compound. Thus, the use of as little as 0.1 ribose in the composition substantially enhances the rate~
of formation of the active entity vis-a-vis a composition containin~ only sodium chlorite and one of the organic acids discussed hereinabove.
Stated otherwise, a composition containing the vicinal polyhydroxy compound may be prepared having substantially the same initial germ-killing efficacy in a specified time period as a composition which does not contain the vicinal polyhydroxy compound even though the composition containing the polyhydroxy compound contains substantially much less organic acid and sodium chlorite.
Elowever, such activation of the system results in a more rapid depletion of the chlorite ion in the composition, so that the germ-k-illing activity at a ]ater time period would-be less. The vicinal polyhydroxy compounds may also serve - another purpose in the composition in that it may act as a sweetener or enhance the solubility of the flavoring-agents.
lhe amount of vicinal polyhydroxy compound containing at least two vicinal hydroxy groups may vary widely, but in the present invention there is employed generally less than about 20%, typically ~rom about 0.1% to about 10%, and preferably from about 0.2% to about ~% by weight of the total composition.
Alternatively, or in addition, the composition may contain a large excess of chloride ion in the form of an alkali or an alkaline earth metal salt. The excess may be from about a 10 to about a 100-fold excess by weight of chloride ion of total chlorite ion concentration. Large excesses of chloride ion in acid solutions (below a pH of about 7) cause the chlorite ion to decompose in an accelerated manner, via the formation of chlorous acid to form chlorine dioxide. In a preferred embodiment of the invention where rapid disinfection is required, the composition contains both a high excess o~ chloride ion and 1 33qo66 a sufficient amount of vicinal polyhydroxy compound comprising at least two vicinal hydroxy groups.
The chlorine dioxide liberating compound is generally kept separate from the organic acid prior to use in order to avoid premature reaction of the ingredients.
l'he flavoring agent may be combined with either the organic acid or the chlorine dioxide liberating compound, or both, prior to their admixture.
The oral hygiene compositions of this invention result in improved bactericidal, fungicidal, virucidal and taste properties over presently available commercial oral hygiene compositions and aid in den~al plaque reduction.
The present invention also provides a process for -- producing d;sinfectant oral hygiene compositions. This process comprises admixing: (a) a flavoring agent acceptable for oral hygi~ne compositions, (b) from about 0.03% to about 0.3~ by weight of chlorine dioxide liberating compound based upon the total weight of the composition, and (c) a suitable amount of an organic acid which as a pK of from about 2.8 to about 4.2. The composition contains substantia~]y no lactic acid.
The present invention also provides a process for reducing -dental plaque as well as controlling gingivitis and periodontitis in the mouth. This process comprises treating the mouth with an oral hygiene composition. The composition comprises (a) a flavoring agent acceptable for use in the mouth, (b) from about 0.03 to about 0.3 of a chlorine dioxide liberating compound based upon the total weight of the composition, and (c) a suitable amount of an organic acid having a pK of from about 2.8 to about 4.2.
The composition contains substantially no lactic acid.
The present invention is il]ustrated by the following examples. Unless otherwise noted, all parts and 3~ percentages in the examples as well as the specification and claims are by weight.
EXAMPrJ~ I
This example illustrates the preparation of a , toothpaste composition according to the present invention.
There is prepared a two-part disinfectant toothpa~te composition according to the invention having a first base paste or gel and a second ac~ivator paste or gel.
The formulations of the two toothpaste parts on a percent weight to weight basis are as follows:
TOOTHPASTE
BASE % W/W
Poly(sulionic Acid) l16~ aqueous solidsl 45.0 Sodium hydroxide, lN 40.0 Bentonite 2.0 15 Sodium lauryl sulfate 1.0 Titanium dioxide 1.0 Silica, amorphous 0.5 Sodium chlorite l.0 Water q.s 20 ACTIVA'rOR
G]ycerin l0.0 Magnesium a]uminum silicate 5.0 Hydroxyethylcellulose 2.0 Malic acid 1.5 Flavor, wintergreen 0.4 FD&C Blue #1 (0.5% solution) 0.06 Sodium benzoate 0.05 25 sodium saccharine Water q.s The p~l of the composition resulting from the mixture of substantially equal portions of ~he base and activator gels of the above formulation is about 4.15.
The base gel and the activator gel are preferably stored separately prior to use, e.g., in a double-compar~-ment tube. The two g~ls are mixed, preferably just prior to use, in substantially equal amounts and the mixture is used in the normal manner as a toothpaste. Alternatively, substantially equal portions of the gels are placed in the mouth and mixed by the brushing action while the subject brushes his or her teeth.
EXAMPLE II
This example iLlustrates the use of the present invention as a teat dip for application to cow udders.
~ first gel is prepared by mixing the following ingredients:
]0 Rheothik~80-ll poly(sulfonic acid) i]6% aqueous solidsJ l6.00%
NaOH, lN 16.Q0 Naconnol*90F (sodium dodecylbenzene sulfonate~ 1.80~
Sodium chlorite 0.64%
Na~FDTA 0.19%
~ Sil~T-600 (silica) 2.50-~z 15 Water q.s.
A second gel is prepared by mixing the following ingredients:
20 I.actic acid 2.6~%
Natrosol 250MR 1.00%
Isopropyl alcohol 2.00%
Sodium benzoate o.o~%
Po3oxamer~188 0.40%
FD&C Yellow #5 0 30%
Water q.s.
The two solutions are blended, preferably just prior to application. The resulting gel is applied to the cow teat, forming a solid shield around the teat. The film thus formed, following drying, provides a long-lasting and continuously acting disinfectant in direct contact with the skin surface.
EXAME'LE III
l'his example illustrates the preparation of a topical gel useful for the treatment of infection-based facial acne.
A first gel is prepared by mixing the following-ingredients:
~n Rheothik 80-ll poly(sulfonic acid) l16~ aqueous solids~ 45.00Oz NaOIl, lN 38.00 Naconnol 90F l.80%
Na4E~TA 0.19%
NaClO2 2.50%
Deionized water q.s.
A second gel is prepared by mixing the following ingredients:
Salieylie aeid 2.00~
Isopropyl alcohol 30.00%
Sodium benzoate o.o~%
Natrosol~250MR 2.10%
P~uronic~-68 0.~0%
Deionized water 65.46%
l'he first and second solutions are mixed, preferably just prior to use. The resulting gel is applied to the a~fected region of the skin. A film forms, creating a long-lasting eover that provides a continuous supply of disin~ectant to the covered area of skin for a prolonged period of time.
EXAMI'LE ~V
This example illustrates the properties of compositions employing hydroxyethyl cellulose as a gelling ager-t for sodium chlorite in the preparation of a final composition comprising sodium chlorite and ]act;c acid.
Example I is repeated, but hydroxyethyl cellulose is used at the 2~ level in place of the polysulfonic acid salt and excluding ~he sodium hydroxide. This gel is not storage stable for a commercially acceptable period of time.
l'he cellulose gelling agent depolymerizes and loses viscosity.
EXAMPLE V
This example illustrates the preparation of a mouthwash according to the present invention.
A first solution is prepared by dissolving 0.4 grams of technical grade sodium chlorite, 0.17 grams of powdered Na4EDTA 4l~2O, 0.5 grams of l-carvone (mint flavor), and the appropriate amount of a compatible food grade yellow dye in 500 milliliters of aqueous solution. A
second solution is prepared by dissolving 1.375 grams of anhydrous citric acid and the appropriate amount of E'D&C
Blue #1 in a batch of 500 milliliters of a ]0 percent by weight aqueous solution of glycerin.
The two solutions are mixed, preferably just prior to use, in substantially equal amounts and the mixture is used in the normal manner as a mouthwash.
EXAMPLE VI
This example also illustrates the preparation of a mouthwash according to the present invention.
A first aqueous solution o~ 0.25% sodium chlorite and 0.10% NaOI~ in deionized water is prepared.
A second aqueous activator solution is prepared of 0.75% malic acid, 10.00% glycerine USP, 0.05% sodium benzoate, 0.50% Equal (aspartame diluted with dextrose and corn syrup solids), 0.03% FD~C Blue #1 (0.3% solution), and 0.40% Wintergreen Flavor (BBA),- in deionized water.
The two solu-tions are mixed, preferably just prior to use in substantially equal amounts, -and the mixt~re is used in the normal manner as a mouthwash.
EXAMPLE VII
This example illustrates the ability o~ a composition of the present invention to reduce dental plaque and control gingivitis and periodontitis.
Mouthwash compositions according to the invention were used in a five day triple-crossover plaque reduction test. In this test, 18 human subjects were divided into three groups of six subjects each. The teeth of each subject were scraped free of plaque immediately prior to the commencement of each five day period.
Each group was subjected to three five day periods of treatment with the following formulations:
(a) placebo, (b) low potency mouthwash formulation, and (c) high potency mouthwash formulation. The sequence of the treatments per group were selected in a random fashion.
During the tive day period the subjects rinsed with the formulation twice daily, i.e., in the morning and afternoon.
The subjects did not brush their teeth or perform any other oral hygiene procedures. The same treatment procedure was followed ~or all three of the formulations. Plaque scores after each five day period were determined by a modified Quigley-Hein index.
The placebe was formulated so that it had substantially the same perceived acidity as the other two formulations. The placebo formulation comprised an aqueous so]ution of 0.27% citric acid, 0.08% sodium chloride, 0.5%
l-carvone, 0.09~z FD&C Green #3 (5000 ppm solution), 0.03%
ED&C YelLow #5 (5000 ppm solution), and 5.0% glycerin.
The compositions were formulated in two parts, A
and B. Equal volumes of the two parts were mixed immediately before rinsing. The percent compositions o~
parts A and B of the high potency and ]ow potency formulations were as follows:
INGREDIENT IIIGH POT~NCY LOW POTENCY
Part A
Sodium chlorite (79~) 0.32 0.08 l-Carvone 0.10 0.10 ED&C Green #3 (5000 ppm solution) 0.18 0.18 1 N Sodium hydroxide q.s. q.s.
Part B
Malic acid 0.75 0.275 Sodium benzoate 0.05 0.05 Glycerin 10.00 10.00 FD&C Yellow #5 (5000 ppm solution) q.s. q.s.
The average plaq~le scores of the subjects listed below show that the mouthwash compositions of this invention were effective in substantially reducing dental plaque.
Score (average) ~ Reduction Placebo 3.82 ---Low potency 3.35 12.3 lligh potency 2.47 35.3 EXAMPLE VIII
An evaluation was made of the microbiocidal effectiveness of the High Potency mouthwash (0.32% Sodium chlorite - Part A; 0.75% Malic acid - Part B) in Example VII, versus that of 0.2% chlorhexidine digluconate. The 0.2% Chlorhexidine digluconate solution is the recommended reference standard by which other oral hygiene germicides should be measured. The procedure employed was based on the method in the F~A OTC Oral E3ealth Care Monograph (Federal Register, Vol. 47, No. 10l, May 25, 1982, pages 22890-22900). The test organisms were:
Candida albicans ATCC 18804 (American Type Culture Collection, Rockville, Md.) Actinobacillus actinomycetemcomitans Forsyth Clinic Isolate #Y4 Streptococcus mutans ATCC 25175 The microorganisms were grown in Brain ~leart Infusion, and subcultured for two successive days at 37~C.
Two ml of a 50:50 mix of each test organism in sterile fetal calf serum was added to 8 ml of the mouthwash formulation, and triplicate aliquots of the inoculated test formulation were removed at 30 and 60 second for subculture.
C. albicans was grown and subcultured aerobically; all other organisms, anaerobically. The ~igh Potency test solutions were neutralized first in fluid thioglycolate medium, and ~urther neutra]ized in the plate count agar.
The chlorhexidine digluconate control solutions were only neutralized in the enumeration agar. Results obtained were as ~ollows:
Average Microbial Test Log Reduction*
Formulation Organism 30 Sec. Exp. 60 Sec. FJXP.
Iligh Potency C. albicans 3.2 3.0 Actinobacillus 7.5 7.5 Strep. mutans 3.5 4.3 Chlorhexidine C. albicans 3.2 3.3 digluconate, 0.2~ Actinobacillus 6.6 6.3 Strep. mutans 3.0 3.0 *Average of three results.
The High Potency Formulation shows a microbiocidal efficacy equal to or greater than of chlorhexidine digluconate at the 0.2% level.
These microbiocidaL data strongly indicate that these formu]ations will not onl,y be helpful in reducing dental plaque formation, but also would inhibit the onset and severity of gi,ngivitis and other associated oral disorders such as periodontitis which could lead to eventual tooth loss.
' The principles, preferred embodiments, and modes of operation of the invention have been described in the foregoing specification. I~owever, the invention herein which is intended to be protected, is not to be construed as limi~ed to the particular forms disclosed, since these are to be regarded as illustrative rather than restrictive.
Variations and changes may be made by those skilled in the art without departing ~rom the spirit of the invention.
Claims (18)
1. A composition for disinfecting a substrate comprising two parts, wherein said first part comprises an aqueous solution or gel containing a suitable amount of a protic acid; and wherein said second part comprises an aqueous solution or gel containing a metal chlorite such that, when the parts are combined, the chlorite ion concentration in the form of chlorous acid is not more than 15% of the total chlorite ion concentration, with the proviso that said composition contains substantially no lactic acid.
2. The composition of claim 1 wherein said composition contains from 0.01% to 0.5% by weight metal chlorite based upon the total weight of said composition.
3. The composition of claim 1 wherein said composition contains from 0.03% to 0.3% by weight metal chlorite based upon the total weight of said composition.
4. The composition of claim 1 wherein said composition contains from 0.02% to 0.05% by weight metal chlorite based upon the total weight of said composition.
5. The composition of claim 1 wherein said metal chlorite is sodium chlorite.
6. The composition of claim 1 wherein said composition contains from 0.01% to 3% by weight protic acid based upon the total weight of said composition.
7. The composition of claim 1 wherein said composition contains from 0.5%
to 2% by weight protic acid based upon the total weight of said composition.
to 2% by weight protic acid based upon the total weight of said composition.
8. The composition of claim 1 wherein said composition contains from 0.1 %
to 1% by weight protic acid based upon the total weight of said composition.
to 1% by weight protic acid based upon the total weight of said composition.
9. The composition of claim 1 wherein said protic acid is carbonic acid.
10. The composition of claim 1 wherein said protic acid is an organic acid having a pK of from 2.8 to 4.2, and wherein the pH of said combined composition is from 2.2 to 7Ø
11. The composition of claim 10 wherein said organic acid is selected from the group consisting of citric, malic, tartaric, glycolic, mandelic and salicylic acids.
12. The composition of claim 1 further comprising a flavoring agent.
13. The composition of claim 12 wherein said flavoring agent is selected from the group consisting of 1-carvone, aspartame, saccharin, peppermint oil, wintergreen oil, cinnamon oil, clove oil, menthol, thymol and eucalyptol.
14. The composition of claim 1 further comprising at least a 10-fold molar excess of a water-soluble chloride ion compared to the total concentration of chlorite ion.
15. The composition of claim 1 further comprising a compound that contains at least two vicinal hydroxy groups.
16. A process for producing a disinfecting composition comprising admixing two parts, wherein said first part comprises an aqueous solution or gel containing a suitable amount of a protic acid and wherein said second part comprises an aqueous solution or gel containing a metal chlorite such that, when the parts are combined, the chlorite ion concentration in the form of chlorous acid is not more than 15% of the total chlorite ion concentration, with the proviso that said composition contains substantially no lactic acid.
17. The process of claim 16 wherein at least one of said first and second parts further comprises a flavoring agent.
18. The process of claim 16 wherein said protic acid is an organic acid having a pK of from 2.8 to 4.2, and wherein the metal chlorite is present in said second part in an amount such that said composition contains from 0.03% to 0.3% by weight of metal chlorite based upon the total weight of said composition.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US038,016 | 1987-04-14 | ||
| US07/038,016 US4891216A (en) | 1987-04-14 | 1987-04-14 | Disinfecting compositions and methods therefor |
| CA000563942A CA1337587C (en) | 1987-04-14 | 1988-04-12 | Disinfecting compositions and methods therefor |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000563942A Division CA1337587C (en) | 1987-04-14 | 1988-04-12 | Disinfecting compositions and methods therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1339066C true CA1339066C (en) | 1997-07-29 |
Family
ID=25671833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000617009A Expired - Lifetime CA1339066C (en) | 1987-04-14 | 1995-05-23 | Disinfecting compositions and methods therefor |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA1339066C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013100346A (en) * | 2006-08-28 | 2013-05-23 | Honbusankei Co Ltd | Process for producing aqueous solution containing chlorous acid for use as bactericide |
| AU2013205834B2 (en) * | 2006-08-28 | 2015-04-09 | Honbu Sankei Co., Ltd | Process for producing aqueous chlorous acid solution for use as disinfectant |
| AU2015203851B2 (en) * | 2006-08-28 | 2017-01-05 | Honbu Sankei Co., Ltd | Process for producing aqueous chlorous acid solution for use as disinfectant |
-
1995
- 1995-05-23 CA CA000617009A patent/CA1339066C/en not_active Expired - Lifetime
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013100346A (en) * | 2006-08-28 | 2013-05-23 | Honbusankei Co Ltd | Process for producing aqueous solution containing chlorous acid for use as bactericide |
| EP2633757A3 (en) * | 2006-08-28 | 2013-11-06 | Honbu Sankei Co., Ltd. | Process for producing aqueous chlorous acid solution for use as bactericide |
| US8951576B2 (en) | 2006-08-28 | 2015-02-10 | Honbu Sankei Co., Ltd. | Process for producing aqueous chlorous acid solution for use as disinfectant |
| AU2013205834B2 (en) * | 2006-08-28 | 2015-04-09 | Honbu Sankei Co., Ltd | Process for producing aqueous chlorous acid solution for use as disinfectant |
| JP2015145418A (en) * | 2006-08-28 | 2015-08-13 | 本部三慶株式会社 | Method for producing aqueous solution containing chlorous acid used as disinfectant |
| EP2984931A1 (en) * | 2006-08-28 | 2016-02-17 | Honbu Sankei Co., Ltd. | Process for producing aqueous chlorous acid solution for use as bactericide |
| AU2015203851B2 (en) * | 2006-08-28 | 2017-01-05 | Honbu Sankei Co., Ltd | Process for producing aqueous chlorous acid solution for use as disinfectant |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1337587C (en) | Disinfecting compositions and methods therefor | |
| US5100652A (en) | Disinfecting oral hygiene compositions and process for using the same | |
| US7592025B2 (en) | Vehicles for oral care with magnolia bark extract | |
| US5116602A (en) | Antiplaque oral compositions | |
| US4786492A (en) | Method and composition for prevention and treatment of oral disease | |
| US20030180247A1 (en) | Two-part disinfecting systems and compositions and methods relating thereto | |
| EP1868438B1 (en) | Acidified chlorite disinfectant compositions with olefin stabilizers | |
| JPH0745368B2 (en) | Disinfecting composition and method of using the same | |
| CH671695A5 (en) | ||
| EP4044996B1 (en) | Oral care composition | |
| WO2021074164A1 (en) | Oral care compositon | |
| CA1339066C (en) | Disinfecting compositions and methods therefor | |
| US20030207945A1 (en) | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | |
| WO2002050008A2 (en) | Non-halogenated phenoxy and/or benzyloxy phenols and antimicrobial compositions containing them | |
| KR20000024742A (en) | Toothpaste containing chitosan | |
| WO2002050002A1 (en) | Non-halogenated phenyl substituted phenols, antimicrobial compositions containing the same, and methods of using the same | |
| DE3855561T2 (en) | AGENT FOR PREVENTING DENTAL COVERAGE AND COATING-RELATED DISEASES | |
| WO2003053897A1 (en) | Non-halogenated hydroxyalkyl-substituted phenol compounds, antimicrobial compositions containing the same, and methods of using the same | |
| DE3028782A1 (en) | Oral compsn. for stimulating collagen prodn. - contg. zinc salt and ascorbic acid, has synergistic antimicrobial activity | |
| US20030139479A1 (en) | Non-halogenated biphenyl triol compounds, antimicrobial compositions containing the same, and methods of using the same | |
| KR20040054875A (en) | Composition for cleaning to toothbrush |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |
Effective date: 20140729 |